Format

Send to

Choose Destination
J Genet Couns. 2018 Feb;27(1):124-130. doi: 10.1007/s10897-017-0129-0. Epub 2017 Jul 11.

Uptake of Predictive Genetic Testing and Cardiac Evaluation for Children at Risk for an Inherited Arrhythmia or Cardiomyopathy.

Author information

1
Department of Medical Genetic, University of Alberta, 826 Medical Sciences Building, Edmonton, AB, T6G 2H7, Canada. Susan.Christian@ahs.ca.
2
Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
3
Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
4
Department of Medical Genetics, Alberta Health Services, Calgary, AB, Canada.
5
Department of Medical Genetic, University of Alberta, 826 Medical Sciences Building, Edmonton, AB, T6G 2H7, Canada.

Abstract

Predictive genetic testing in minors should be considered when clinical intervention is available. Children who carry a pathogenic variant for an inherited arrhythmia or cardiomyopathy require regular cardiac screening and may be prescribed medication and/or be told to modify their physical activity. Medical genetics and pediatric cardiology charts were reviewed to identify factors associated with uptake of genetic testing and cardiac evaluation for children at risk for long QT syndrome, hypertrophic cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy. The data collected included genetic diagnosis, clinical symptoms in the carrier parent, number of children under 18 years of age, age of children, family history of sudden cardiac arrest/death, uptake of cardiac evaluation and if evaluated, phenotype for each child. We identified 97 at risk children from 58 families found to carry a pathogenic variant for one of these conditions. Sixty six percent of the families pursued genetic testing and 73% underwent cardiac screening when it was recommended. Declining predictive genetic testing was significantly associated with genetic specialist recommendation (p < 0.001) and having an asymptomatic carrier father (p = 0.006). Cardiac evaluation was significantly associated with uptake of genetic testing (p = 0.007). This study provides a greater understanding of factors associated with uptake of genetic testing and cardiac evaluation in children at risk of an inherited arrhythmia or cardiomyopathy. It also identifies a need to educate families about the importance of cardiac evaluation even in the absence of genetic testing.

KEYWORDS:

Arrhythmogenic right ventricular cardiomyopathy; Children; Genetic testing; Hypertrophic cardiomyopathy; Long QT syndrome; Predictive

PMID:
28699125
DOI:
10.1007/s10897-017-0129-0

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center